ResMed Inc.
RMD
$219.72
-$0.50-0.23%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.70% | 0.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.70% | 0.11% | |||
| Cost of Revenue | 4.72% | -0.01% | |||
| Gross Profit | 4.69% | 0.19% | |||
| SG&A Expenses | 1.10% | -1.33% | |||
| Depreciation & Amortization | -2.06% | -0.91% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.30% | -0.57% | |||
| Operating Income | 7.73% | 1.60% | |||
| Income Before Tax | 9.08% | 7.20% | |||
| Income Tax Expenses | 2.16% | 10.15% | |||
| Earnings from Continuing Operations | 10.68% | 6.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.68% | 6.54% | |||
| EBIT | 7.73% | 1.60% | |||
| EBITDA | 7.45% | 1.78% | |||
| EPS Basic | 10.72% | 6.58% | |||
| Normalized Basic EPS | 9.30% | 2.98% | |||
| EPS Diluted | 10.90% | 6.55% | |||
| Normalized Diluted EPS | 9.35% | 2.90% | |||
| Average Basic Shares Outstanding | -0.03% | -0.04% | |||
| Average Diluted Shares Outstanding | -0.08% | 0.04% | |||
| Dividend Per Share | 0.00% | 10.42% | |||
| Payout Ratio | -0.10% | 0.04% | |||
